A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
Müller L, Mauthe RJ, Riley CM, Andino MM, Antonis DD, Beels C, DeGeorge J, De Knaep AG, Ellison D, Fagerland JA, Frank R, Fritschel B, Galloway S, Harpur E, Humfrey CD, Jacks AS, Jagota N, Mackinnon J, Mohan G, Ness DK, O'Donovan MR, Smith MD, Vudathala G, Yotti L.
Müller L, et al. Among authors: mauthe rj.
Regul Toxicol Pharmacol. 2006 Apr;44(3):198-211. doi: 10.1016/j.yrtph.2005.12.001. Epub 2006 Jan 18.
Regul Toxicol Pharmacol. 2006.
PMID: 16412543